TABLE 1.
RNA-modulating prions, amyloids, and amyloidogenic proteins
Gene / Protein | Amyloid (Prion)* | Functions of the protein** | Effects of prion or amyloid state | Organism | Compositionally biased regions*** |
---|---|---|---|---|---|
URE2 / Ure2 | [URE3] | Transcriptional regulator of the nitrogen catabolism | Blocks interaction of Ure2 with Gln380 that causes preference of poor nitrogen sources | S. cerevisiae | N, Q/N |
SWI1 / Swi1 | [SWI+] | Transcriptional regulator, subunit of SWI/SNF chromatin remodeling complex | Inhibits growth on the media with non-fermentable carbon sources,40 provides resistance to benomyl14 | S. cerevisiae | A, N, Q, Q/N, T |
SUP35 / Sup35 | [PSI+] | Translation release factor eRF3, mRNA decay | Reduces efficiency of translation termination178 | S. cerevisiae | E, G, K, Q, Q/N, Y |
MOT3 / Mot3 | [MOT3+] | Transcription factor modulating mating, carbon metabolism, and stress response | Regulates flocculation; induction by ethanol and elimination by hypoxia85 | S. cerevisiae | A, H, N, P, Q, Q/N |
CYC8 / Cyc8 | [OCT+] | Transcriptional repressor and activator, subunit of Cyc8-(Ssn6)-Tup1 complex | Inhibits growth of the strains bearing cyc1 deletion on the media with non-fermentable carbon source lactate41 | S. cerevisiae | A, E, P, Q/N, Q |
SFP1 / Sfp1 | [ISP+] | Transcription regulator of genes encoding ribosomal proteins; regulates response to nutrients and stress | Antisuppression of nonsense mutations;87 enhances resistance to cycloheximide and paromomycin42 | S. cerevisiae | A, D, H, N, Q, Q/N, T |
PUB1 / Pub1 | [PUB1] | Stress granule assembly, 3′UTR mRNA-binding | Unclear; aggregates co-localize with P-bodies / stress granules45 | S. cerevisiae | M, N, Q, Q/N |
PUB1 and SUP35 / Pub1 and Sup35 | [PUB1 / SUP35] | Stress granule assembly / Translation release factor eRF3 | Formation of microtubule-associated cytoskeleton-associated complex carrying translational machinery and important for maintaining the integrity of the microtubular cytoskelton45 | S. cerevisiae | E, G, K, M, N, Q, Q/N, Y |
TIA1 / TIA1 | [TIA1] | Stress granule assembly, 3′UTR mRNA-binding | Amyloid-like fibrils involved in stress granule assembly111 | M. musculus | Q |
NUP100 / Nup100 | [NUP100+] | Subunit of nuclear pore complex; nucleocytoplasmic transport | Unknown, phenotypic manifestation is absent43 | S. cerevisiae | G, N, Q, Q/N, S, T |
TP53 / p53 | p53, mutant | Transcriptional repressor | Amyloid-like oligomers and fibrils associated with carcinogenesis104,105 | H. sapiens | A, P |
HTT / huntingtin | huntingtin, mutant | Transcriptional regulator | Pathological amyloid-like inclusions associated with Huntington's disease91 | H. sapiens | D, L, P, Q, Q/N, V |
ATN / atrophin-1 | atrophin-1, mutant | Transcriptional repressor | Pathological amyloid-like inclusions associated with dentatorubral pallidoluysian atrophy94 | H. sapiens | D, E, G, H, P, Q, Q/N, R, S |
TNRC6A / TNRC6A | TNRC6A | RNA-binding, component of P-bodies, involved in the regulation of post-transcriptional gene silencing through the RNA interference | Fibrils in P-bodies, function is unclear120 | H. sapiens | G, K, N, P, Q, Q/N, S, T, W, |
DDX6 / DDX6 | DDX6 | RNA helicase found in P-bodies and stress granules, involved in translation suppression and mRNA degradation | Fibrils in P-bodies, function is unclear121 | H. sapiens | Q |
TDP43 / TDP43 | TDP43, mutant | Transcriptional repressor, component of stress-granules | Pathological inclusions associated with frontotemporal dementia and amyotrophic lateral sclerosis127-129 | H. sapiens | G, N |
FUS / FUS | FUS, mutant | RNA-binding, component of hnRNP-complex | Pathological inclusions associated with amyotrophic lateral sclerosis and polyglutamine diseases131,132 | H. sapiens | G, Q, R, S, Y |
HNRNPA1 / hnRNPA1 | hnRNPA1, mutant | RNA-binding, involved in the packaging of pre-mRNA into hnRNP particles, transport of poly-A mRNA from the nucleus to the cytoplasm | Pathological, multisystem proteinopathy-associated intracellular amyloid-like inclusions136 | H. sapiens | G |
HNRNPA2B1 / hnRNPA2B1 | hnRNPA2B1, mutant | RNA-binding, associated with pre-mRNAs in the nucleus | Pathological, multisystem proteinopathy-associated intracellular amyloid-like inclusions136 | H. sapiens | G, Y |
CPEB / CPEB | CPEB | RNA-binding, binds U-rich sequence located in the 3′ untranslated regions of mRNAs, thus either promoting, or inhibiting translation | Functional amyloid involved in the control of long-term memory; induction by 5HT24,159 | A. californica | P, Q, Q/N, S |
orb2 / Orb2A | Orb2A | see above (CPEB) | see above (CPEB); induction by dopamine, octopamine, or tyramine161,169 | D. melanogaster | G, H, M, Q, Q/N, S |
CPEB3 / CPEB3 | CPEB3 | see above (CPEB) | see above (CPEB); induction by dopamine, glutamate, or glycine59,162,163 | M. musculus | A, P, Q, Q/N |
Column indicates the special designation of amyloid (or prion, in the case of yeast prions).
Based on data from the NCBI Gene database (http://www.ncbi.nlm.nih.gov/gene/), Saccharomyces Genome Database (http://www.yeastgenome.org/), and cited studies.
Overrepresented amino acids are shown. CBRs were predicted by SARP algorithm,179 and the probability thresholds were set to 10−6 for single residue CBRs and 10−12 for multiple residues CBRs to reduce false positives. CBRs for multiple residue were predicted for the Q/N pair only.